The Oncology Institute Inc
(TOI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -35,368 | -19,889 | -83,068 | -64,314 | -46,895 |
| Depreciation Amortization | 5,680 | 2,724 | 26,314 | 25,084 | 20,943 |
| Income taxes - deferred | 0 | N/A | -76 | 50 | -30 |
| Accounts receivable | -11,657 | -16,400 | -4,564 | -8,657 | -6,576 |
| Accounts payable and accrued liabilities | 898 | 6,357 | 5,057 | 3,961 | 3,751 |
| Other Working Capital | -6,138 | -2,732 | 2,359 | -4,087 | -2,976 |
| Other Operating Activity | 15,042 | 14,057 | 17,663 | 15,541 | 7,671 |
| Operating Cash Flow | $-31,543 | $-15,883 | $-36,315 | $-32,422 | $-24,112 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,436 | -610 | -4,567 | -3,706 | -2,776 |
| Net Acquisitions | N/A | N/A | -4,456 | -4,300 | -4,300 |
| Purchase Of Investment | N/A | N/A | -9,595 | -9,683 | -9,747 |
| Sale Of Investment | 40,000 | 19,998 | 81,258 | 68,702 | 60,127 |
| Investing Cash Flow | $37,564 | $19,388 | $62,640 | $51,013 | $43,304 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -18 | -9 | -101 | -91 | -81 |
| Common Stock Issued | 75 | 73 | 126 | 13 | 0 |
| Common Stock Repurchased | N/A | N/A | -1,019 | -1,019 | -894 |
| Other Financing Activity | -3,142 | -1,002 | -5,853 | -3,969 | -3,335 |
| Financing Cash Flow | $-3,085 | $-938 | $-6,847 | $-5,066 | $-4,310 |
| Beginning Cash Position | 33,488 | 33,488 | 14,010 | 14,010 | 14,010 |
| End Cash Position | 36,424 | 36,055 | 33,488 | 27,535 | 28,892 |
| Net Cash Flow | $2,936 | $2,567 | $19,478 | $13,525 | $14,882 |
| Free Cash Flow | |||||
| Operating Cash Flow | -31,543 | -15,883 | -36,315 | -32,422 | -24,112 |
| Capital Expenditure | -2,436 | -610 | -4,567 | -3,706 | -2,776 |
| Free Cash Flow | -33,979 | -16,493 | -40,882 | -36,128 | -26,888 |